Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CNS CoTSE:4076 86 3-Year ROIIC % is 21.90 as of May. 2026, which is 36% above its 10-year median of 16.06. GuruFocus rates TSE:4076 with a GF Score™ of 86/100 and a GF Value™ of 円1,855.96 (Fairly Valued). The stock has 3 warning signs investors should review. Among 2,624 Software companies, CNS Co ranks better than 69.21% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
CNS Co's 3-Year ROIIC % for the quarter that ended in May. 2026 was 21.90%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for CNS Co's 3-Year ROIIC % or its related term are showing as below:
TSE:4076's 3-Year ROIIC % is ranked better than 69.21% of 2624
companies
in the Software industry
Industry Median: 5.345
vs TSE:4076: 21.90
CNS Co (TSE:4076) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
CNS Co 3-Year ROIIC % Related Terms
CNS Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for CNS Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4076 vs IBM, ACN, FISV: 3-Year ROIIC % Comparison
For the Information Technology Services subindustry, CNS Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CNS Co 3-Year ROIIC % vs Software Industry
For the Software industry and Technology sector, CNS Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where CNS Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
CNS Co (TSE:4076) has a 3-Year ROIIC % of 21.90 as of May. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on CNS Co and its competitors. This is 36% above median its historical median of 16.06. According to the industry distribution chart, CNS Co ranks #808 out of 2624 companies in the Software industry, placing it in the top 30.8%.
Is CNS Co's 3-Year ROIIC % too high?
CNS Co's current 3-Year ROIIC % of 21.90 is 36% above median its 10-year median of 16.06. The Software industry median 3-Year ROIIC % is 5.35. CNS Co's value of 21.90 is 309.7% above this industry median. Based on the distribution chart, CNS Co ranks #808 out of 2624 companies in the Software industry, which is above the industry midpoint. Overall, CNS Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's 3-Year ROIIC % compare to IBM and ACN?
According to the Software industry distribution chart, CNS Co ranks #808 out of 2624 companies for 3-Year ROIIC %. This puts CNS Co in the upper half of its industry. The industry median 3-Year ROIIC % is 5.35. CNS Co's value of 21.90 is 309.7% above this benchmark. While the company's 10-year median is 16.06 vs. the industry median of 5.35, CNS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Software company?
The median 3-Year ROIIC % among Software companies is 5.35, based on 2,624 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CNS Co's current 3-Year ROIIC % of 21.90 is 309.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on CNS Co and its competitors. For the Software industry, the median 3-Year ROIIC % is 5.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CNS Co's current 3-Year ROIIC % is 21.90, which is 36% above median its own 10-year median of 16.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Fairly Valued. The stock's GF Value™ is 円1,855.96, compared to a current price of 円1,838.00 — trading 1% below its estimated fair value. The current 3-Year ROIIC % is 21.90, which is 36% above median its 10-year median of 16.06 and 309.7% above the Software industry median of 5.35. CNS Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For CNS Co (TSE:4076), the current 3-Year ROIIC % is 21.90 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CNS Co (TSE:4076) Overvalued in 2026?
Based on GuruFocus' analysis, CNS Co stock appears to be undervalued.
The current stock price of 円1,838.00 is trading 1% below its estimated GF Value™ of 円1,855.96.
GuruFocus considers CNS Co to be Fairly Valued.
Key valuation signals for TSE:4076:
3-Year ROIIC %: 21.90 (36% above median its 10-year median of 16.06)
GF Value™: 円1,855.96 vs. price of 円1,838.00 (1% below fair value)
Industry Position: 309.7% above the Software median (#808 of 2624)
No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
86GF Score
Get the complete analysis for TSE:4076
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4076 has been successfully added to your 
